• Latest Posts

OSE Immunotherapeutics announces latest acute lymphoblastic leukemia data

Significant therapeutic potential of OSE Immunotherapeutics’ CLEC-1 published

Servier and OSE Immunotherapeutics complete enrollment in Sjögren’s syndrome trial

In Depth 6 Jul 2020

How Immuno-Oncology Contributes to the Fight Against Covid-19

French Partnership Deploys AI for Antibody Drug Discovery


Artificial Intelligence Could Beat Tumors Resistant to Immunotherapy

Boehringer Offers €1Bn for New Checkpoint Inhibitor from a French Biotech

Immunotherapy for Bowel Disease Gets €2.6M Milestone Payment from Bpifrance

French Biotech Enters New Agreement to Advance its IBD Immunotherapy

Catching Up with the French Leader in Immuno-Oncology #BIOEurope